BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Capasso A, Benigni A, Capitanio U, Danesh FR, Di Marzo V, Gesualdo L, Grandaliano G, Jaimes EA, Malyszko J, Perazella MA, Qian Q, Ronco P, Rosner MH, Trepiccione F, Viggiano D, Zoccali C, Capasso G, Akitaka A, Alahoti A, Alexander TR, Altucci L, Amer H, Barone V, Benigni A, Biancone L, Bonventre JV, Camussi G, Capasso A, Ciardiello F, Capitanio U, Caraglia M, Cartenì G, Cervantes A, Citterio F, Cosmai L, Danesh FR, Daniele B, D’errico A, De Vita F, Di Marzo V, Ereditato A, Falco G, Fouque D, Franco R, Gallieni M, Gambaro G, Gesualdo L, Grandaliano G, Kuo C, Jaimes EA, Launay-vacher V, Maiello E, Mallamaci F, Malysxko J, Marino G, Martinelli E, Matarese G, Matsubara T, Messa P, Messina C, Mirone V, Morgillo F, Costa AN, Orditura M, Pani A, Perazella MA, Perna A, Pisano C, Pitts T, Porta C, Procopio G, Qian Q, Remuzzi G, Ronco P, Rosner MH, Russo D, Siu LL, Stadler W, Trepiccione F, Troiani T, Viggiano D, Weisz A, Więcek A, Xiaoqiang D, Zecchino O, Zoccali C. Summary of the International Conference on Onco-Nephrology: an emerging field in medicine. Kidney International 2019;96:555-67. [DOI: 10.1016/j.kint.2019.04.043] [Cited by in Crossref: 31] [Cited by in F6Publishing: 30] [Article Influence: 7.8] [Reference Citation Analysis]
Number Citing Articles
1 Dobbin SJ, Herrmann SM, Lang NN, Herrmann J, Touyz RM. Hypertension and renal disease prevention before cancer therapy. Cardio-Oncology Practice Manual : a Companion to Braunwald 's Heart Disease 2023. [DOI: 10.1016/b978-0-323-68135-3.00020-9] [Reference Citation Analysis]
2 Hałka J, Spaleniak S, Kade G, Antosiewicz S, Sigorski D. The Nephrotoxicity of Drugs Used in Causal Oncological Therapies. Curr Oncol 2022;29:9681-94. [PMID: 36547174 DOI: 10.3390/curroncol29120760] [Reference Citation Analysis]
3 Vanhoutte T, Sprangers B. Serum cystatin C level can be used to estimate GFR in patients with solid tumors: Moderator Commentary. Journal of Onco-Nephrology 2022. [DOI: 10.1177/23993693221114901] [Reference Citation Analysis]
4 Delaye M, Try M, Campedel L, Corbaux P, Rousseau A, Isnard Bagnis C. Development and organization of onco-nephrology in France, comment on “The path toward the creation of the American Society of Onco-Nephrology (ASON)”. Journal of Onco-Nephrology 2022. [DOI: 10.1177/23993693221106490] [Reference Citation Analysis]
5 Tang L, Li C, Chen W, Zeng Y, Yang H, Hu Y, Song H, Zeng X, Li Q, Fu P. Causal Association between Chronic Kidney Disease and Risk of 19 Site-Specific Cancers: A Mendelian Randomization Study. Cancer Epidemiol Biomarkers Prev 2022;31:1233-42. [PMID: 35333923 DOI: 10.1158/1055-9965.EPI-21-1318] [Reference Citation Analysis]
6 Pirovano M, Cosmai L. Nephrological management of renal cell carcinoma (RCC) patients: A narrative review. Journal of Onco-Nephrology 2022. [DOI: 10.1177/23993693221098444] [Reference Citation Analysis]
7 Costa E Silva VT, Gil LA Jr, Inker LA, Caires RA, Costalonga E, Coura-Filho G, Sapienza MT, Castro G Jr, Estevez-Diz MD, Zanetta DMT, Antonângelo L, Marçal L, Tighiouart H, Miao S, Mathew P, Levey AS, Burdmann EA. A prospective cross-sectional study estimated glomerular filtration rate from creatinine and cystatin C in adults with solid tumors. Kidney Int 2022:S0085-2538(21)01209-6. [PMID: 35032521 DOI: 10.1016/j.kint.2021.12.010] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
8 Martinez Cantarin MP, Mejia C. Onconephrology. Approaches to Chronic Kidney Disease 2022. [DOI: 10.1007/978-3-030-83082-3_11] [Reference Citation Analysis]
9 Masaki C, Sugino K, Kobayashi S, Hosoi Y, Ono R, Yamazaki H, Akaishi J, Hames KY, Tomoda C, Suzuki A, Matsuzu K, Ohkuwa K, Kitagawa W, Nagahama M, Ito K. Impact of lenvatinib on renal function: long-term analysis of differentiated thyroid cancer patients. BMC Cancer 2021;21:894. [PMID: 34353305 DOI: 10.1186/s12885-021-08622-w] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
10 Alonso F, Auñón P, Cavero T, Salgueira M, Praga M, Quiroga B, de Francisco ÁLM, Macía M; Grupo Español de Onconefrología (ONCONEFRO). Monographic consultation of onconephrology. Rationale and implementation. Nefrologia 2021;41:154-64. [PMID: 34167768 DOI: 10.1016/j.nefroe.2021.04.006] [Reference Citation Analysis]
11 Bridoux F, Cockwell P, Glezerman I, Gutgarts V, Hogan JJ, Jhaveri KD, Joly F, Nasr SH, Sawinski D, Leung N. Kidney injury and disease in patients with haematological malignancies. Nat Rev Nephrol 2021;17:386-401. [PMID: 33785910 DOI: 10.1038/s41581-021-00405-7] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
12 Mielczarek Ł, Brodziak A, Sobczuk P, Kawecki M, Cudnoch-Jędrzejewska A, Czarnecka AM. Renal toxicity of targeted therapies for renal cell carcinoma in patients with normal and impaired kidney function. Cancer Chemother Pharmacol 2021;87:723-42. [PMID: 33768301 DOI: 10.1007/s00280-021-04260-y] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
13 García-Carro C, Bolufer M, Bury R, Catañeda Z, Muñoz E, Felip E, Lorente D, Carreras MJ, Gabaldon A, Agraz I, Serón D, Soler MJ. Acute kidney injury as a risk factor for mortality in oncological patients receiving check-point inhibitors. Nephrol Dial Transplant 2021:gfab034. [PMID: 33547795 DOI: 10.1093/ndt/gfab034] [Cited by in Crossref: 6] [Cited by in F6Publishing: 12] [Article Influence: 3.0] [Reference Citation Analysis]
14 Viggiano D, Lee MW, Simeoni M, Capasso G, Capasso A. A new hypothesis to explain skin cancer risk in kidney allograft recipients. Journal of Onco-Nephrology 2021;5:3-7. [DOI: 10.1177/2399369320972122] [Reference Citation Analysis]
15 Huang L, Shen Y, Liu C, Li C, Wang J. [Palbociclib induces cell cycle arrest and senescence of human renal tubular epithelial cells in vitro]. Nan Fang Yi Ke Da Xue Xue Bao 2020;40:1784-92. [PMID: 33380388 DOI: 10.12122/j.issn.1673-4254.2020.12.13] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
16 Cosmai L, Porta C, Foramitti M, Perrone V, Mollica L, Gallieni M, Capasso G. Preventive strategies for acute kidney injury in cancer patients. Clin Kidney J 2021;14:70-83. [PMID: 33564407 DOI: 10.1093/ckj/sfaa127] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.7] [Reference Citation Analysis]
17 Smirnov AV, Dobronravov VA, Khrabrova MS, Afanasyev BV. Kidney involvement in monoclonal gammopathies: multidisciplinary approach in oncohematology and nephrology. Onkogematologiâ 2020;15:49-60. [DOI: 10.17650/1818-8346-2020-15-2-49-60] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
18 Piscitani L, Sirolli V, Di Liberato L, Morroni M, Bonomini M. Nephrotoxicity Associated with Novel Anticancer Agents (Aflibercept, Dasatinib, Nivolumab): Case Series and Nephrological Considerations. Int J Mol Sci 2020;21:E4878. [PMID: 32664269 DOI: 10.3390/ijms21144878] [Cited by in Crossref: 11] [Cited by in F6Publishing: 13] [Article Influence: 3.7] [Reference Citation Analysis]
19 Malyszko J, Lee MW, Capasso G, Kulicki P, Matuszkiewicz-rowinska J, Ronco P, Stevens P, Tesarova P, Viggiano D, Capasso A. How to assess kidney function in oncology patients. Kidney International 2020;97:894-903. [DOI: 10.1016/j.kint.2019.12.023] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
20 Masaki C, Sugino K, Kobayashi S, Akaishi J, Hames KY, Tomoda C, Suzuki A, Matsuzu K, Uruno T, Ohkuwa K, Kitagawa W, Nagahama M, Ito K. Urinalysis by combination of the dipstick test and urine protein-creatinine ratio (UPCR) assessment can prevent unnecessary lenvatinib interruption in patients with thyroid cancer. Int J Clin Oncol. 2020;25:1278-1284. [PMID: 32347432 DOI: 10.1007/s10147-020-01678-x] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.7] [Reference Citation Analysis]
21 Thongprayoon C, Hansrivijit P, Kovvuru K, Kanduri SR, Torres-Ortiz A, Acharya P, Gonzalez-Suarez ML, Kaewput W, Bathini T, Cheungpasitporn W. Diagnostics, Risk Factors, Treatment and Outcomes of Acute Kidney Injury in a New Paradigm. J Clin Med 2020;9:E1104. [PMID: 32294894 DOI: 10.3390/jcm9041104] [Cited by in Crossref: 22] [Cited by in F6Publishing: 25] [Article Influence: 7.3] [Reference Citation Analysis]
22 Shah A, Hu SL. Kidney Failure with Urinary Tract Cancers. CJASN 2020;15:447-449. [DOI: 10.2215/cjn.01850220] [Reference Citation Analysis]
23 Smirnov AV, Afanasyev BV, Poddubnaya IV, Dobronravov VA, Khrabrova MS, Zakharova EV, Nikitin EA, Kozlovskaya LV, Bobkova IN, Rameev VV, Batyushin MM, Moiseev ШS, Darskaya EI, Pirogova OV, Mendeleeva LP, Biryukova LS. Monoclonal Gammopathy of Renal Significance: Consensus of Hematologists and Nephrologists of Russia on the Establishment of Nosology, Diagnostic Approach and Rationale for Clone Specific Treatment. Arhivʺ vnutrennej mediciny 2020;10:102-118. [DOI: 10.20514/2226-6704-2020-10-2-102-118] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
24 Steinel NC, Lee EM, Viggiano D, Capasso A, Lee MW. The renal adverse effects of cancer immunotherapy. J Nephrol 2020;33:467-81. [PMID: 31912436 DOI: 10.1007/s40620-019-00691-2] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
25 Smirnov AV, Afanasyev BV, Poddubnaya IV, Dobronravov VA, Khrabrova MS, Zakharova EV, Nikitin EA, Kozlovskaya LV, Bobkova IN, Rameev VV, Batyushin MM, Moiseev IS, Darskaya EI, Pirogova OV, Mendeleeva LP, Biryukova LS. Monoclonal gammopathy of renal signifi cance: Consensus of hematologists and nephrologists of Russia on the establishment of nosology, diagnostic approach and rationale for clone specific treatment. Nefrologiâ (St -Peterbg ) 2019;23:9-28. [DOI: 10.36485/1561-6274-2019-236-9-28] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]